378 related articles for article (PubMed ID: 31419519)
1. Rodent ketamine depression-related research: Finding patterns in a literature of variability.
Polis AJ; Fitzgerald PJ; Hale PJ; Watson BO
Behav Brain Res; 2019 Dec; 376():112153. PubMed ID: 31419519
[TBL] [Abstract][Full Text] [Related]
2. The Ketamine Antidepressant Story: New Insights.
Alshammari TK
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297563
[TBL] [Abstract][Full Text] [Related]
3. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
4. An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions.
Lewis V; Rurak G; Salmaso N; Aguilar-Valles A
Trends Neurosci; 2024 Mar; 47(3):195-208. PubMed ID: 38220554
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research.
Lv S; Yao K; Zhang Y; Zhu S
Neuropharmacology; 2023 Mar; 225():109378. PubMed ID: 36539011
[TBL] [Abstract][Full Text] [Related]
6. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
Lauterbach EC
Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
[TBL] [Abstract][Full Text] [Related]
7. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.
Aleksandrova LR; Phillips AG; Wang YT
J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice.
Zhang F; Hillhouse TM; Anderson PM; Koppenhaver PO; Kegen TN; Manicka SG; Lane JT; Pottanat E; Van Fossen M; Rice R; Porter JH
Pharmacol Biochem Behav; 2021 Sep; 208():173228. PubMed ID: 34224734
[TBL] [Abstract][Full Text] [Related]
11. The rapid-onset antidepressant effect of ketamine: More surprises?
Raffa RB; Pergolizzi JV; Taylor R;
J Clin Pharm Ther; 2018 Apr; 43(2):308-311. PubMed ID: 29178131
[TBL] [Abstract][Full Text] [Related]
12. Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists.
Pozzi L; Pollak Dorocic I; Wang X; Carlén M; Meletis K
PLoS One; 2014; 9(1):e83879. PubMed ID: 24454710
[TBL] [Abstract][Full Text] [Related]
13. [A review of the antidepressant properties of ketamine].
Desfossés CY; Blier P
Med Sci (Paris); 2021 Jan; 37(1):27-34. PubMed ID: 33492215
[TBL] [Abstract][Full Text] [Related]
14. (
Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
16. An update on NMDA antagonists in depression.
Pochwat B; Nowak G; Szewczyk B
Expert Rev Neurother; 2019 Nov; 19(11):1055-1067. PubMed ID: 31328587
[No Abstract] [Full Text] [Related]
17. Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.
Wei Y; Chang L; Hashimoto K
Mol Psychiatry; 2022 Jan; 27(1):559-573. PubMed ID: 33963284
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
Hashimoto K
Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141
[TBL] [Abstract][Full Text] [Related]
19. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
Nguyen L; Matsumoto RR
Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
[TBL] [Abstract][Full Text] [Related]
20. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]